Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging ...

CAR T-cell therapy is starting to enter the treatment conversations sooner with patients with multiple myeloma, according to ...

Multiple myeloma is a type of blood cancer that affects plasma cells, a kind of white blood cell found in the bone marrow.

Multiple myeloma begins when abnormal cells multiply and grow uncontrollably in a person’s bone marrow, crowding out healthy ...

Dear Dr. Roach: I am 86 years old. Nine years ago I overcame non-Hodgkin's lymphoma. Now, my oncologist tells me I have multiple myeloma. I read up about it, and ...

Financial, family, and logistical challenges often lead patients to choose ongoing therapies over stem cell transplantation, ...

Cilta-cel therapy significantly enhances survival rates in lenalidomide-refractory multiple myeloma, outperforming standard ...

JNJ wins CHMP backing for Darzalex and Imbruvica in new blood cancer uses, paving the way for first-in-class approvals.

Why do some patients with precursors to bone marrow cancer never develop the disease? Researchers from the Department of ...

Early results from the MagnetisMM-6 trial reveal promising efficacy of elranatamab, daratumumab, and lenalidomide in treating ...

A "Trojan horse" therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world ...